Africa has launched its first continent-wide medical regulator, marking a major step toward strengthening local pharmaceutical capacity and reducing reliance on foreign oversight. The initiative, the African Medicines Agency (AMA), aims to overcome Africa’s current fragmented drug approval process, where medicines approved in one African country often face delays in another.
By harmonizing standards, the agency will accelerate access to safe and effective treatments for millions. Currently, only nine of Africa’s 55 nations meet WHO regulatory standards, and just 3% of global clinical trials take place on the continent.
The AMA aims to change this reality by boosting local clinical research, ensuring that new drugs and vaccines are developed with African populations in mind.
ENTEBBE, Uganda, 27 October 2026 -/African Media Agency(AMA)/ - When nine-year-old James Ssemambo developed severe…
International Space Station’s use of tabular AI and expanded partnerships demonstrate the art of the…
UNICEF says a conditional deal could lower the RTS,S malaria vaccine price by about 40%…
An African Development Bank report points to faster growth while warning that Zambia still faces…
A partnership backed by a $1 million grant is mapping skills demand and planning local…
The financing is designed to cushion energy costs while supporting Botswana’s private-sector and jobs reforms.